Your browser doesn't support javascript.
loading
Association of tumor-infiltrating lymphocytes with distant disease-free survival in the ShortHER randomized adjuvant trial for patients with early HER2+ breast cancer.
Dieci, M V; Conte, P; Bisagni, G; Brandes, A A; Frassoldati, A; Cavanna, L; Musolino, A; Giotta, F; Rimanti, A; Garrone, O; Bertone, E; Cagossi, K; Sarti, S; Ferro, A; Piacentini, F; Maiorana, A; Orvieto, E; Sanders, M; Miglietta, F; Balduzzi, S; D'Amico, R; Guarneri, V.
Affiliation
  • Dieci MV; Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova; Medical Oncology 2, Istituto Oncologico Veneto IRCCS, Padova.
  • Conte P; Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova; Medical Oncology 2, Istituto Oncologico Veneto IRCCS, Padova. Electronic address: pierfranco.conte@unipd.it.
  • Bisagni G; Oncology Unit, Department of Oncology and Advanced Technologies, Azienda USL-IRCCS, Reggio Emilia.
  • Brandes AA; Medical Oncology, Azienda Unità Sanitaria Locale di Bologna-IRCCS Istituto delle Scienze Neurologiche, Bologna.
  • Frassoldati A; Clinical Oncology, Department of Morphology, Surgery and Experimental Medicine, S Anna University Hospital, Ferrara.
  • Cavanna L; Department of Oncology-Hematology, G. da Saliceto Hospital, Piacenza.
  • Musolino A; Medical Oncology Unit, University Hospital of Parma, Piacenza.
  • Giotta F; Division of Medical Oncology, IRCCS, Istituto Tumori "Giovanni Paolo II", Bari.
  • Rimanti A; Medical Oncology, Azienda Ospedaliera di Mantova, Mantova.
  • Garrone O; Medical Oncology, A.O. S. Croce and Carle Teaching Hospital, Cuneo.
  • Bertone E; Medical Oncology, S. Anna Hospital, Torino.
  • Cagossi K; Breast Unit Ausl Modena, Ramazzini Hospital, Carpi.
  • Sarti S; Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST), IRCCS, Meldola.
  • Ferro A; Rete Clinica Senologica - Oncologia Medica S. Chiara, Trento.
  • Piacentini F; Division of Medical Oncology, Department of Medical and Surgical Sciences for Children & Adults, University Hospital of Modena, Modena; Azienda Ospedaliero-Universitaria di Modena, Modena.
  • Maiorana A; Department of Diagnostic, Clinical Medicine and Public Health, University Hospital of Modena, Modena.
  • Orvieto E; Pathology Unit, Ulss 5 Polesana, Rovigo, Italy.
  • Sanders M; Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, USA.
  • Miglietta F; Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova.
  • Balduzzi S; Department of Medical and Surgical Sciences for Children & Adults, University Hospital of Modena, Italy.
  • D'Amico R; Department of Medical and Surgical Sciences for Children & Adults, University Hospital of Modena, Italy.
  • Guarneri V; Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova; Medical Oncology 2, Istituto Oncologico Veneto IRCCS, Padova.
Ann Oncol ; 30(3): 418-423, 2019 03 01.
Article in En | MEDLINE | ID: mdl-30657852
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Breast Neoplasms / Lymphocytes, Tumor-Infiltrating / Receptor, ErbB-2 / Trastuzumab Type of study: Clinical_trials / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Middle aged Language: En Year: 2019 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Breast Neoplasms / Lymphocytes, Tumor-Infiltrating / Receptor, ErbB-2 / Trastuzumab Type of study: Clinical_trials / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Middle aged Language: En Year: 2019 Type: Article